Patent · US Active

Multispecific antibodies, multispecific activatable antibodies and methods of using the same

US11161906B2 · kind B2 · utility

7Cited by

34References

45Claims

0Family size

Assignee

CytomX Therapeutics, Inc. · US

Inventors

Henry B. Lowman · El Granada, US
James William West · Lompoc, US
Sherry Lynn La Porte · Horsham, US
Bryan Irving · Woodside, US
Daniel Robert Hostetter · Palo Alto, US
Chihunt Wong · Corona, US

Key dates

Filing date	Jul 25, 2014
Grant date	Nov 2, 2021
Priority date	—
Expiry date	Jul 25, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention relates generally to multispecific antibodies and to multispecific activatable antibodies that specifically bind to two or more different antigens or epitopes, as well as to methods of making and using these multispecific antibodies and/or multispecific activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.